Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people notice semaglutide beginning to work within the first one to two weeks, though meaningful weight loss typically takes four to eight weeks to become visible on the scales. The medicine starts reducing appetite almost immediately after the first dose, but the body needs several weeks at an effective dose before fat loss accumulates enough to measure. Semaglutide is a prescription-only medicine, and a prescriber assesses whether it is clinically suitable for you before treatment can begin.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture the morning after your first Wegovy injection. You sit down to breakfast and, for once, finish half of it and feel done. That is the medicine working, and it often happens faster than people expect. Semaglutide acts on GLP-1 receptors in the brain and gut, slowing gastric emptying and reducing hunger signals within days of the first dose.
What it does not do in those early weeks is shift significant weight. The starting dose of 0.25 mg is a tolerability step: its job is to let your body adjust to the medicine, not to deliver the full appetite effect. Many people feel a little nauseous, notice some fatigue, or experience changes in digestion, all of which the NHS medicines page for semaglutide describes as common and usually temporary. Worrying that the medicine "isn't working" at this stage is understandable, but premature. Give it time.
Scale movement in weeks one and two is possible (mostly from reduced calorie intake) but tends to be modest. Focus instead on how your hunger feels across the day. That shift is the earliest reliable sign that semaglutide is beginning to take effect, and our dedicated guide on how long for semaglutide to kick in walks through exactly what to watch for in those opening days.
A question our prescribers hear most weeks is some version of: "I've been on it a month and I've only lost a couple of kilos, should I be worried?" Almost always, the answer is no. This is the phase where titration does its slow, deliberate work.
Every four weeks or so, the dose steps up (from 0.25 mg to 0.5 mg, then 1.0 mg, then 1.7 mg, then 2.4 mg) with the prescriber reviewing suitability at each stage. Weight loss tends to accelerate as the dose rises, because the appetite effect strengthens with each increase. By the end of week twelve, many people are either at or approaching the 1.7 mg step, and total weight loss of four to eight per cent of starting body weight is a realistic benchmark. Some people lose more, some less. How quickly semaglutide works depends heavily on which dose you are currently taking.
This is also when the lifestyle piece starts to matter more. The medicine reduces hunger; it does not redesign eating habits automatically. People who combine it with protein-rich meals and regular activity tend to see faster progress than those who rely on the injection alone. Not a judgement, just what the data shows.
By the time a person reaches the 2.4 mg maintenance dose and has spent a few weeks at that level, the cumulative effect of sustained appetite reduction becomes clear on the scales. The STEP 1 trial (68 weeks, 2.4 mg semaglutide against placebo) found an average reduction of roughly 15% of body weight. That figure is a clinical-trial average across a large group; real-world results sit either side of it.
If you are wondering how long before Wegovy kicks in at its full strength, the honest answer is around sixteen weeks to reach the maintenance dose, then further weeks of accumulated loss beyond that. For a more detailed breakdown of the early timeline specifically, our page on how long until Wegovy kicks in covers the dose-by-dose picture in full. Expecting dramatic changes at week four is setting the wrong clock. Expecting steady, compounding progress from week four through to month six is reasonable.
Progress does slow for most people after the initial period of loss, and occasional plateaus are normal. A prescriber can review whether the maintenance dose is being tolerated well, whether there are any adjustments to consider, and whether any side effects are worth addressing. That ongoing clinical oversight is part of why this treatment works best within a structured service rather than in isolation. For context on what private treatment involves, the Wegovy price page explains what a responsible, all-inclusive service covers. And if you are ever uncertain about your treatment, our support team is available seven days a week.
Not everyone moves through the timeline smoothly. If the scales have not shifted at all after eight to twelve weeks at a therapeutic dose (not the starter dose), that is worth discussing with your prescriber rather than assuming the medicine has failed. A few possibilities: the dose may still be at the lower end; dietary patterns may be offsetting the reduced appetite; or, in a smaller number of cases, the individual response to semaglutide is genuinely limited.
The NICE appraisal of semaglutide (TA875) notes that continuing treatment should be reviewed if weight loss is less than 5% after six months at the maintenance dose. That threshold exists because, for some people, a different approach (or a different medicine) may serve them better. It is a clinical judgment, not a failure. If you are exploring options, our weight-loss treatment overview covers what is licensed in the UK and how the medicines compare. A brief free consultation with one of our prescribers is the right first step; check your eligibility here.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.